These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17653856)

  • 21. Molecular profiling and targeted therapy for advanced thoracic malignancies: a biomarker-derived, multiarm, multihistology phase II basket trial.
    Lopez-Chavez A; Thomas A; Rajan A; Raffeld M; Morrow B; Kelly R; Carter CA; Guha U; Killian K; Lau CC; Abdullaev Z; Xi L; Pack S; Meltzer PS; Corless CL; Sandler A; Beadling C; Warrick A; Liewehr DJ; Steinberg SM; Berman A; Doyle A; Szabo E; Wang Y; Giaccone G
    J Clin Oncol; 2015 Mar; 33(9):1000-7. PubMed ID: 25667274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High expression of cyclin D1 is associated to high proliferation rate and increased risk of mortality in women with ER-positive but not in ER-negative breast cancers.
    Ahlin C; Lundgren C; Embretsén-Varro E; Jirström K; Blomqvist C; Fjällskog M-
    Breast Cancer Res Treat; 2017 Aug; 164(3):667-678. PubMed ID: 28528450
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Chen Y; Huang Y; Gao X; Li Y; Lin J; Chen L; Chang L; Chen G; Guan Y; Pan LK; Xia X; Guo Z; Pan J; Xu Y; Yi X; Chen C
    Front Immunol; 2020; 11():1620. PubMed ID: 32903763
    [No Abstract]   [Full Text] [Related]  

  • 24. Deciphering the Immune Microenvironment at the Forefront of Tumor Aggressiveness by Constructing a Regulatory Network with Single-Cell and Spatial Transcriptomic Data.
    Xu K; Yu D; Zhang S; Chen L; Liu Z; Xie L
    Genes (Basel); 2024 Jan; 15(1):. PubMed ID: 38254989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Machine learning for genetics-based classification and treatment response prediction in cancer of unknown primary.
    Moon I; LoPiccolo J; Baca SC; Sholl LM; Kehl KL; Hassett MJ; Liu D; Schrag D; Gusev A
    Nat Med; 2023 Aug; 29(8):2057-2067. PubMed ID: 37550415
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Parabens Promote Protumorigenic Effects in Luminal Breast Cancer Cell Lines With Diverse Genetic Ancestry.
    Tapia JL; McDonough JC; Cauble EL; Gonzalez CG; Teteh DK; Treviño LS
    J Endocr Soc; 2023 Jul; 7(8):bvad080. PubMed ID: 37409182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms.
    Rezaee M; Mohammadi F; Keshavarzmotamed A; Yahyazadeh S; Vakili O; Milasi YE; Veisi V; Dehmordi RM; Asadi S; Ghorbanhosseini SS; Rostami M; Alimohammadi M; Azadi A; Moussavi N; Asemi Z; Aminianfar A; Mirzaei H; Mafi A
    Front Pharmacol; 2023; 14():1152672. PubMed ID: 37153758
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nuclear Epidermal Growth Factor Receptor Overexpression as a Survival Predictor in Oral Squamous Cell Carcinoma.
    Tarle M; Raguž M; Muller D; Lukšić I
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982894
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-canonical approaches to targeting hypoxic tumors.
    Zhao S; El-Deiry WS
    Am J Cancer Res; 2022; 12(12):5351-5374. PubMed ID: 36628275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comprehensive Genomic Profiling of Cell-Free Circulating Tumor DNA Detects Response to Ribociclib Plus Letrozole in a Patient with Metastatic Breast Cancer.
    Silveira C; Sousa AC; Corredeira P; Martins M; Sousa AR; Da Cruz Paula A; Selenica P; Brown DN; Golkaram M; Kaplan S; Zhang S; Liu L; Weigelt B; Reis-Filho JS; Costa L; Carmo-Fonseca M
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551247
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancer.
    Yousefi H; Bahramy A; Zafari N; Delavar MR; Nguyen K; Haghi A; Kandelouei T; Vittori C; Jazireian P; Maleki S; Imani D; Moshksar A; Bitaraf A; Babashah S
    BMC Cancer; 2022 Dec; 22(1):1282. PubMed ID: 36476410
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclin genes as potential novel prognostic biomarkers and therapeutic targets in breast cancer.
    Liu NQ; Cao WH; Wang X; Chen J; Nie J
    Oncol Lett; 2022 Oct; 24(4):374. PubMed ID: 36238849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissecting Molecular Heterogeneity of Circulating Tumor Cells (CTCs) from Metastatic Breast Cancer Patients through Copy Number Aberration (CNA) and Single Nucleotide Variant (SNV) Single Cell Analysis.
    Rossi T; Angeli D; Tebaldi M; Fici P; Rossi E; Rocca A; Palleschi M; Maltoni R; Martinelli G; Fabbri F; Gallerani G
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36010918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic and Predictive Value of
    Jeffreys SA; Becker TM; Khan S; Soon P; Neubauer H; de Souza P; Powter B
    Front Endocrinol (Lausanne); 2022; 13():895729. PubMed ID: 35784572
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cyclin-Dependent Kinase 4/6 Inhibitors: A Potential Breakthrough Therapy for Malignancies of Gastrointestinal Tract.
    Zeng F; Zhou Y; Khowtanapanich T; Saengboonmee C
    In Vivo; 2022; 36(4):1580-1590. PubMed ID: 35738597
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gene Mutations Associated With Clinical Characteristics in the Tumors of Patients With Breast Cancer.
    Hao C; Wang C; Lu N; Zhao W; Li S; Zhang L; Meng W; Wang S; Tong Z; Zeng Y; Lu L
    Front Oncol; 2022; 12():778511. PubMed ID: 35494043
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CCND1 Amplification in Breast Cancer -associations With Proliferation, Histopathological Grade, Molecular Subtype and Prognosis.
    Valla M; Klæstad E; Ytterhus B; Bofin AM
    J Mammary Gland Biol Neoplasia; 2022 Mar; 27(1):67-77. PubMed ID: 35459982
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fusion transcripts and their genomic breakpoints in polyadenylated and ribosomal RNA-minus RNA sequencing data.
    Hoogstrate Y; Komor MA; Böttcher R; van Riet J; van de Werken HJG; van Lieshout S; Hoffmann R; van den Broek E; Bolijn AS; Dits N; Sie D; van der Meer D; Pepers F; Bangma CH; van Leenders GJLH; Smid M; French PJ; Martens JWM; van Workum W; van der Spek PJ; Janssen B; Caldenhoven E; Rausch C; de Jong M; Stubbs AP; Meijer GA; Fijneman RJA; Jenster GW
    Gigascience; 2021 Dec; 10(12):. PubMed ID: 34891161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circulating Tumor Cells as a Tool to Untangle the Breast Cancer Heterogeneity Issue.
    Rossi T; Gallerani G; Martinelli G; Maltoni R; Fabbri F
    Biomedicines; 2021 Sep; 9(9):. PubMed ID: 34572427
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intra-tumoral distribution of Ki-67 and Cyclin D1 in ER+ mammary carcinoma: quantitative evaluation.
    Latifa M; Fatima DD; Farida M; Rachid S
    Afr Health Sci; 2021 Mar; 21(1):41-46. PubMed ID: 34394279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.